Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma

BJU International

Volumn 102, Issue 11, 2008, Pages 1610-1614

  Zini, Laurent ^a,c   Perrotte, Paul ^b   Jeldres, Claudio ^a   Capitanio, Umberto ^a,e   Pharand, Daniel ^b   Arjane, Philippe ^b   Lapointe, Steven ^b   Montorsi, Francesco ^e   Patard, Jean Jacques ^d   Karakiewicz, Pierre I ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cancer specific survival; Conservative management; Kidney neoplasm; Locally advanced stage; Natural history; Renal cell carcinoma

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 56649117744     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07917.x     Document Type: Article

References (20)

1. McGivney WT. The CMS 2006 Quality in Oncology Demonstration Project and NCCN Guidelines. J Natl Compr Canc Netw 2006 4 : 2
2. Kader AK, Tamboli P, Luongo T et al. Cytoreductive nephrectomy in the elderly patient: the M.D. Anderson Cancer Center experience. J Urol 2007 177 : 855 60
3. Rodriguez A, Sexton WJ. Management of locally advanced renal cell carcinoma. Cancer Control 2006 13 : 199 210
4. Wood CG. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res 2007 13 : 697s 702s
5. Baird AD, Woolfenden KA, Desmond AD, Fordham MV, Parsons KF. Outcome and survival with non-surgical management of renal cell carcinoma. BJU Int 2003 91 : 600 2
6. Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 2007 100 : 1235 9
7. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer 2007 109 : 2439 44
8. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol 2007 178 : 1878 82
9. Ries LAG, Melbert D, Krapcho M et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD : National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2004/ based on November 2006 SEER data submission, posted to the SEER web site. Last accessed January 2007
10. Hutterer GC, Patard JJ, Colombel M et al. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma. Cancer 2007 110 : 2428 33
11. Kelsey JL, Whittemore AS, Evans AS, Douglas Thompson WD. Methods in Observational Epidemiology, 2nd edn. Oxford : Oxford University Press, 1996
12. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999 94 : 496 509
13. Klatte T, Pantuck AJ, Riggs SB et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 2007 178 : 1189 95
14. Karakiewicz PI, Trinh QD, Bhojani N et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2007 51 : 1616 24
15. Karakiewicz PI, Hutterer GC, Trinh QD et al. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 2007 110 : 1241 7
16. Karakiewicz PI, Briganti A, Chun FK et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 2007 25 : 1316 22
17. Walz J, Gallina A, Saad F et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007 25 : 3576 81
18. Gill IS, Kavoussi LR, Lane BR et al. Comparison of 1800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007 178 : 41 6
19. Mouraviev V, Nosnik I, Robertson C, Albala D, Walther P, Polascik TJ. Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience. Eur Urol 2007 51 : 715 20
20. Patard JJ, Rioux-Leclercq N, Fergelot P. Understanding the importance of smart drugs in renal cell carcinoma. Eur Urol 2006 49 : 633 43